- Home
- Publications
- Publication Search
- Publication Details
Title
Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-02-10
DOI
10.3389/fonc.2022.815900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Treatment Landscape of Advanced Angiosarcoma in Asia—A multi‐National Collaboration From The asian Sarcoma Consortium
- (2021) Tom Wei‐Wu Chen et al. CANCER SCIENCE
- Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma
- (2021) Davendra P. S. Sohal et al. JAMA Oncology
- Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
- (2021) Miao Liu et al. BMC CANCER
- Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer
- (2021) Priyanka Sharma et al. CLINICAL CANCER RESEARCH
- nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial
- (2021) Peter Oppelt et al. MEDICAL ONCOLOGY
- Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature
- (2021) Anna M. Frezza et al. Cancer Medicine
- Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
- (2021) Daniel Pink et al. Cancers
- Comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel including sequential treatment for metastatic pancreatic cancer: a propensity score matching approach
- (2021) Jung Won Chun et al. BMC CANCER
- Phase 3 trial comparing nab-paclitaxel with docetaxel for previously treated advanced non–small cell lung cancer
- (2021) Yasuto Yoneshima et al. Journal of Thoracic Oncology
- Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB–IIIB resectable lung squamous cell carcinoma
- (2021) Dijian Shen et al. Journal of Thoracic Disease
- Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
- (2021) Jie Wang et al. JAMA Oncology
- The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer
- (2021) Jiangfeng Wang et al. Annals of Translational Medicine
- Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
- (2021) D. Miles et al. ANNALS OF ONCOLOGY
- Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis
- (2021) Jakob M. Riedl et al. EUROPEAN JOURNAL OF CANCER
- Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles
- (2021) Le Minh Pham et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
- (2021) Naruto Taira et al. Breast Cancer
- SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas
- (2021) Guillem Pascual-Pasto et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis
- (2020) Hwaryeon Lee et al. Scientific Reports
- Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
- (2020) Philip A Philip et al. Lancet Gastroenterology & Hepatology
- Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
- (2020) Francesco Gelsomino et al. BRITISH JOURNAL OF CANCER
- A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients
- (2020) Herbert J. Zeh et al. CLINICAL CANCER RESEARCH
- Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
- (2020) Catherine A Shu et al. LANCET ONCOLOGY
- Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation
- (2020) Javier E. Oesterheld et al. PEDIATRIC BLOOD & CANCER
- Surgical Outcome Results From SWOG S1505
- (2020) Syed A. Ahmad et al. ANNALS OF SURGERY
- Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
- (2020) Zhichao Tian et al. BMC CANCER
- Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network
- (2020) Loredana Amoroso et al. EUROPEAN JOURNAL OF CANCER
- Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma
- (2020) Giampaolo Perri et al. JAMA Surgery
- Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer
- (2020) Alexander G. Raufi et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study
- (2020) P. Giannatempo et al. ANNALS OF ONCOLOGY
- A Phase I/II study of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer
- (2020) Hisashi Tanaka et al. Clinical Lung Cancer
- Phase II Trial of Neoadjuvant Carboplatin and Nab‐Paclitaxel in Patients with Triple Negative Breast Cancer
- (2020) Yuan Yuan et al. ONCOLOGIST
- Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study
- (2020) Gerald W. Prager et al. EUROPEAN JOURNAL OF CANCER
- NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021
- (2020) Margaret von Mehren et al. Journal of the National Comprehensive Cancer Network
- Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer
- (2020) Junji Tsurutani et al. BREAST
- Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
- (2020) Volker Kunzmann et al. Lancet Gastroenterology & Hepatology
- The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
- (2020) Muyue Yang et al. Bioactive Materials
- Impact of Older Age on the Exposure of Paclitaxel: a Population Pharmacokinetic Study
- (2019) Marie-Rose B. S. Crombag et al. PHARMACEUTICAL RESEARCH
- Current advances in development of new docetaxel formulations
- (2019) Enhui Zhang et al. Expert Opinion on Drug Delivery
- A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
- (2019) Zhen Wang et al. EUROPEAN JOURNAL OF CANCER
- The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2019) Takashi Higuchi et al. BIOMEDICINE & PHARMACOTHERAPY
- First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience
- (2019) A. Parisi et al. Clinical & Translational Oncology
- Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
- (2019) Rachna T. Shroff et al. JAMA Oncology
- A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer
- (2019) Rikiya Hasegawa et al. International Journal of Clinical Oncology
- A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)
- (2019) Hajime Asahina et al. LUNG CANCER
- Sarcoma Surveillance
- (2019) Cara A. Cipriano et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer
- (2019) Yuko Tsuchiya‐Kawano et al. ONCOLOGIST
- Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study
- (2019) Marie-Rose B. S. Crombag et al. PHARMACEUTICAL RESEARCH
- A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer
- (2019) Kan Wu et al. Journal of Thoracic Disease
- Phase I results of a phase I/II study of weekly nab -paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer
- (2018) Lucas Moreno et al. EUROPEAN JOURNAL OF CANCER
- Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial
- (2018) Atsuo Takashima et al. Gastric Cancer
- Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
- (2018) Margaret von Mehren et al. Journal of the National Comprehensive Cancer Network
- Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas
- (2018) Jonathan L. Metts et al. PEDIATRIC BLOOD & CANCER
- A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma
- (2018) Michele Reni et al. EUROPEAN JOURNAL OF CANCER
- Prognostic factors for survival in Ewing sarcoma: A systematic review
- (2018) S.E. Bosma et al. SURGICAL ONCOLOGY-OXFORD
- Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma
- (2018) Vaibhav Sahai et al. JAMA Oncology
- nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2
- (2018) Ajeet Gajra et al. Frontiers in Oncology
- Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
- (2018) Jie Xu et al. BMC CANCER
- Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)
- (2018) S. Watson et al. EUROPEAN JOURNAL OF CANCER
- Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
- (2018) Teresa Macarulla et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma
- (2018) Jee Hung Kim et al. ONCOLOGY
- Developments and future clinical outlook of taxane nanomedicines
- (2017) Benoit Louage et al. JOURNAL OF CONTROLLED RELEASE
- Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
- (2017) Beatrice Seddon et al. LANCET ONCOLOGY
- Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel
- (2017) Jessica Ley et al. MEDICAL ONCOLOGY
- Phase II Study of Modified Carboplatin Plus Weekly Nab‐Paclitaxel in Elderly Patients with Non‐Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
- (2017) Eisaku Miyauchi et al. ONCOLOGIST
- Osteogenic Sarcoma: A 21st Century Review
- (2016) STEPHEN OSASAN et al. ANTICANCER RESEARCH
- Weekly nanoparticle albumin bound-paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma
- (2016) Haiying Wang et al. OncoTargets and Therapy
- Phase II Study of Nab-Paclitaxel and Bevacizumab as First-line Therapy for Patients with Unresectable Stage III and IV Melanoma
- (2015) Lynn E. Spitler et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A randomized, controlled phase III trial ofnab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma
- (2015) E. M. Hersh et al. ANNALS OF ONCOLOGY
- Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
- (2015) Nianhang Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CCR 20th Anniversary Commentary: Setting the Stage for Nanoparticle Albumin-Bound Paclitaxel--How Far Science Has Come
- (2015) S. I. Bashour et al. CLINICAL CANCER RESEARCH
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)
- (2015) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase II open-label clinical study of comparing nab-paclitaxel with pemetrexed as second-line chemotherapy for patients with stage IIIB/IV non-small-cell lung cancer
- (2015) Zhefeng Liu et al. MEDICAL ONCOLOGY
- Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations
- (2015) Yan Li et al. MOLECULAR PHARMACEUTICS
- A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas
- (2015) R. R. Munhoz et al. ONCOLOGIST
- A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer
- (2015) J. E. Grilley-Olson et al. ONCOLOGIST
- Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane®) by the Pediatric Preclinical Testing Program (PPTP)
- (2015) Peter J. Houghton et al. PEDIATRIC BLOOD & CANCER
- Albumin-bound paclitaxel in solid tumors: clinical development and future directions
- (2015) Madappa Kundranda et al. Drug Design Development and Therapy
- Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review
- (2014) Vincent A. de Weger et al. ANTI-CANCER DRUGS
- Nab-paclitaxel: A flattering facelift
- (2014) A. Viúdez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications
- (2014) David Kudlowitz et al. Expert Opinion On Drug Safety
- How Taxol/paclitaxel kills cancer cells
- (2014) Beth A. Weaver MOLECULAR BIOLOGY OF THE CELL
- Age-Related Changes in Nanoparticle Albumin-Bound Paclitaxel Pharmacokinetics and Pharmacodynamics: Influence of Chronological Versus Functional Age
- (2014) A. Hurria et al. ONCOLOGIST
- Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma
- (2014) Lars M. Wagner et al. PEDIATRIC BLOOD & CANCER
- Clinical features of taxane neuropathy
- (2013) David Kudlowitz et al. ANTI-CANCER DRUGS
- Nab-Paclitaxel Is an Active Drug in Preclinical Model of Pediatric Solid Tumors
- (2013) L. Zhang et al. CLINICAL CANCER RESEARCH
- Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
- (2013) Yoo-Joung Ko et al. LANCET ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of weekly nab(R)-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
- (2012) M. A. Socinski et al. ANNALS OF ONCOLOGY
- Docetaxel Nanotechnology in Anticancer Therapy
- (2012) Pengxiang Zhao et al. ChemMedChem
- Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival
- (2012) William J. Gradishar et al. Clinical Breast Cancer
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on taxane development: new analogs and new formulations
- (2012) Katherine Tkaczuk et al. Drug Design Development and Therapy
- Osteosarcoma
- (2010) J. Ritter et al. ANNALS OF ONCOLOGY
- Phase II Evaluation of Nanoparticle Albumin–Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
- (2009) Michael G. Teneriello et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
- (2008) Nicolas Penel et al. JOURNAL OF CLINICAL ONCOLOGY
- Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer
- (2008) George Dranitsaris et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started